These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25261290)

  • 21. Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.
    Dabbous FM; Dolecek TA; Berbaum ML; Friedewald SM; Summerfelt WT; Hoskins K; Rauscher GH
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):397-403. PubMed ID: 28183826
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.
    Smith CR; Chiarelli AM; Holloway CM; Mirea L; O'Malley FP; Blackmore KM; Pandya A; Majpruz V; Harris CP; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D
    Breast; 2018 Oct; 41():25-33. PubMed ID: 29957557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of screening mammography on breast cancer survival in comparison to other detection methods: a retrospective cohort study.
    Kawai M; Kuriyama S; Suzuki A; Nishino Y; Ishida T; Ohnuki K; Amari M; Tsuji I; Ohuchi N
    Cancer Sci; 2009 Aug; 100(8):1479-84. PubMed ID: 19493274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
    Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
    Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival.
    Nurgalieva ZZ; Franzini L; Morgan R; Vernon SW; Liu CC; Du XL
    Med Oncol; 2013 Dec; 30(4):691. PubMed ID: 23975632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
    Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
    JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between the pre-diagnosis mammography screening interval and advanced breast cancer.
    Goel A; Littenberg B; Burack RC
    Breast Cancer Res Treat; 2007 May; 102(3):339-45. PubMed ID: 16927175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond breast cancer: mammographic features and mortality risk in a population of healthy women.
    Murphy RA; Schairer C; Gierach GL; Byrne C; Sherman ME; Register TC; Ding J; Kritchevsky SB; Harris TB
    PLoS One; 2013; 8(10):e78722. PubMed ID: 24205300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis in women with interval breast cancer: population based observational cohort study.
    Kalager M; Tamimi RM; Bretthauer M; Adami HO
    BMJ; 2012 Nov; 345():e7536. PubMed ID: 23160783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.
    Taplin SH; Abraham L; Geller BM; Yankaskas BC; Buist DS; Smith-Bindman R; Lehman C; Weaver D; Carney PA; Barlow WE
    J Natl Cancer Inst; 2010 Jul; 102(14):1040-51. PubMed ID: 20601590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
    Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K
    Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
    Morrell S; Taylor R; Roder D; Dobson A
    J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
    Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
    Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins and breast cancer stage and mortality in the Women's Health Initiative.
    Desai P; Lehman A; Chlebowski RT; Kwan ML; Arun M; Manson JE; Lavasani S; Wasswertheil-Smoller S; Sarto GE; LeBoff M; Cauley J; Cote M; Beebe-Dimmer J; Jay A; Simon MS
    Cancer Causes Control; 2015 Apr; 26(4):529-39. PubMed ID: 25736184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007.
    Kaplan HG; Malmgren JA; Atwood MK; Calip GS
    Cancer; 2015 Aug; 121(15):2553-61. PubMed ID: 25872471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative.
    Simon MS; Beebe-Dimmer JL; Hastert TA; Manson JE; Cespedes Feliciano EM; Neuhouser ML; Ho GYF; Freudenheim JL; Strickler H; Ruterbusch J; Barac A; Chlebowski R; Caan B
    Cancer; 2018 Apr; 124(8):1798-1807. PubMed ID: 29338086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups.
    Nguyen KH; Pasick RJ; Stewart SL; Kerlikowske K; Karliner LS
    Cancer; 2017 Sep; 123(18):3468-3475. PubMed ID: 28603859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammography surveillance and mortality in older breast cancer survivors.
    Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
    J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.